Literature DB >> 24179007

Obesity and CKD progression: hard facts on fat CKD patients.

Francesca Mallamaci1, Giovanni Tripepi.   

Abstract

Obesity is a worldwide epidemic and there is compelling evidence that excess fat is closely associated with chronic kidney disease (CKD) and end-stage kidney failure. In this review, we will describe some important mechanisms related with the pathogenesis and treatment of CKD in obesity by emphasizing the role of excess fat in renal haemodynamic and structural alterations.

Entities:  

Keywords:  body mass index; chronic kidney disease; obesity

Mesh：

Year:  2013        PMID： 24179007     DOI： 10.1093/ndt/gft391

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN： 0931-0509            Impact factor:   5.992


  22 in total

1.  Anti-inflammatory and Antioxidative Activities of Safranal in the Reduction of Renal Dysfunction and Damage that Occur in Diabetic Nephropathy.

Authors:  Ömer Hazman; Mehmet Fatih Bozkurt
Journal:  Inflammation       Date:  2015-08       Impact factor: 4.092

2.  Adiposity Impacts Intrarenal Hemodynamic Function in Adults With Long-standing Type 1 Diabetes With and Without Diabetic Nephropathy: Results From the Canadian Study of Longevity in Type 1 Diabetes.

Authors:  Petter Bjornstad; Julie A Lovshin; Yuliya Lytvyn; Genevieve Boulet; Leif E Lovblom; Omar N Alhuzaim; Mohammed A Farooqi; Vesta Lai; Josephine Tse; Leslie Cham; Andrej Orszag; Daniel Scarr; Alanna Weisman; Hillary A Keenan; Michael H Brent; Narinder Paul; Vera Bril; Bruce A Perkins; David Z I Cherney
Journal:  Diabetes Care       Date:  2018-02-02       Impact factor: 19.112

3.  Type 2 diabetes treatment and progression of chronic kidney disease in Italian family practice.

Authors:  G Ermini; C Tosetti; D Zocchi; M Mandreoli; M T Caletti; G Marchesini
Journal:  J Endocrinol Invest       Date:  2018-11-21       Impact factor: 4.256

Review 4.  The dual roles of obesity in chronic kidney disease: a review of the current literature.

Authors:  Connie M Rhee; Seyed-Foad Ahmadi; Kamyar Kalantar-Zadeh
Journal:  Curr Opin Nephrol Hypertens       Date:  2016-05       Impact factor: 2.894

5.  Sequence variants of peroxisome proliferator-activated receptor-gamma gene and the clinical courses of patients with end-stage renal disease.

Authors:  Chia-Ter Chao; Yen-Ching Chen; Chih-Kang Chiang; Jenq-Wen Huang; Fu-Chang Hu; Cheng-Chung Fang; Chen-Chih Chang; Chung-Jen Yen
Journal:  Dis Markers       Date:  2015-02-15       Impact factor: 3.434

Review 6.  Hypertension in pediatric patients with chronic kidney disease: management challenges.

Authors:  Claire M Gallibois; Natasha A Jawa; Damien G Noone
Journal:  Int J Nephrol Renovasc Dis       Date:  2017-07-26

7.  Weight change and microvascular outcomes in patients with new-onset diabetes: a nationwide cohort study.

Authors:  Eun Sil Koh; Kyung Do Han; Mee Kyoung Kim; Eun Sook Kim; Min-Kyung Lee; Ga Eun Nam; Hyuk-Sang Kwon
Journal:  Korean J Intern Med       Date:  2021-05-13       Impact factor: 2.884

8.  Weighing the evidence: obesity, metabolic syndrome, and the risk of chronic kidney disease.

Authors:  Ezra Gabbay; Itzchak Slotki; Linda Shavit
Journal:  BMC Nephrol       Date:  2015-08-07       Impact factor: 2.388

9.  Abdominal Obesity, Race and Chronic Kidney Disease in Young Adults: Results from NHANES 1999-2010.

Authors:  Harini Sarathy; Gabriela Henriquez; Matthew K Abramowitz; Holly Kramer; Sylvia E Rosas; Tanya Johns; Juhi Kumar; Amy Skversky; Frederick Kaskel; Michal L Melamed
Journal:  PLoS One       Date:  2016-05-25       Impact factor: 3.240

Review 10.  Weight Loss in Advanced Chronic Kidney Disease: Should We Consider Individualised, Qualitative, ad Libitum Diets? A Narrative Review and Case Study.

Authors:  Irene Capizzi; Luigi Teta; Federica Neve Vigotti; Giuliana Tognarelli; Valentina Consiglio; Stefania Scognamiglio; Giorgina Barbara Piccoli
Journal:  Nutrients       Date:  2017-10-11       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.